Glibenclamide (µM/mL) | |||||
Concentration | 1 | 5 | 50 | 100 | Control |
% Viability | 97.84 ± 2.56 | 96.8 ± 1.45 | 96.32 ± 1.57 | 95.84 ± 1.18 | 100.05 ± 0.08 |
CZME (µg/mL) | |||||
Concentration | 5 | 50 | 500 | 1000 | Control |
% Viability | 99.75 ± 2.24 | 98.79 ± 2.49 | 98.12 ± 2.71 | 96.78 ± 2.31 | 100.01 ± 0.02 |